Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

This is not your grandfather’s Lego. But perhaps your father still plays with the delightful little bricks. Lego is not ...

In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

I’m not going to report record revenue, but it was nonetheless a robust year," CEO Bernard Arnault said during the earnings ...

Meanwhile, Wisconsin Supreme Court race could determine the future of abortion in the state; Minnesota will implement insulin price cap; Denver hospital opens its free naloxone vending machine; and ...

(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, ...

Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 ...

Trump has also questioned whether Denmark, which has controlled Greenland since 1814, has a "legal right" to the territory and predicted that Greenland's people will vote to join the U.S. He ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

Market Structure ? Growth Drivers ? Restraints and Challenges ? Emerging Product Trends & Market Opportunities ? Porter?s Fiver Forces The trend and outlook of global market is forecast in optimistic, ...